Ishita Drugs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE806D01016
  • NSEID:
  • BSEID: 524400
INR
74.01
-4.49 (-5.72%)
BSENSE

Nov 20

BSE+NSE Vol: 445

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Guj. Terce Labs.
Centuple Global
Medi Caps
Ishita Drugs
Venmax Drugs
Lasa Supergeneri
Shree Ganesh Bio
Welcure Drugs
Goldline Pharmac
Bacil Pharma
Mono Pharmacare
Why is Ishita Drugs & Industries Ltd ?
1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 7.62%
  • Poor long term growth as Net Sales has grown by an annual rate of -1.92% and Operating profit at -3.66% over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.82
2
Flat results in Sep 26
  • NET SALES(Latest six months) At Rs 6.18 cr has Grown at -27.04%
  • PBT LESS OI(Q) Lowest at Rs 0.05 cr.
3
Stock is technically in a Mildly Bearish range
  • The stocks MACD and KST technical factors are also Bearish
4
With ROE of 6.3, it has a Expensive valuation with a 1.9 Price to Book Value
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 5.71%, its profits have fallen by -24%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Ishita Drugs for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Ishita Drugs
5.71%
0.09
61.69%
Sensex
-2.0%
-0.13
14.98%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-1.92%
EBIT Growth (5y)
-3.66%
EBIT to Interest (avg)
0.82
Debt to EBITDA (avg)
1.49
Net Debt to Equity (avg)
-0.58
Sales to Capital Employed (avg)
1.44
Tax Ratio
26.53%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
36.73%
ROE (avg)
7.62%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
30
Industry P/E
40
Price to Book Value
1.91
EV to EBIT
15.41
EV to EBITDA
15.41
EV to Capital Employed
3.18
EV to Sales
1.25
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
18.35%
ROE (Latest)
6.31%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company
Icon
NO KEY POSITIVE TRIGGERS
-5What is not working for the Company
NET SALES(Latest six months)

At Rs 6.18 cr has Grown at -27.04%

PBT LESS OI(Q)

Lowest at Rs 0.05 cr.

Loading Valuation Snapshot...
Here's what is not working for Ishita Drugs
Net Sales - Latest six months
At Rs 6.18 cr has Grown at -27.04%
Year on Year (YoY)
MOJO Watch
Near term sales trend is negative

Net Sales (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs 0.05 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is negative

PBT less Other Income (Rs Cr)